BR0011297A - Hibridação subtrativa à base de micro-sistema - Google Patents

Hibridação subtrativa à base de micro-sistema

Info

Publication number
BR0011297A
BR0011297A BR0011297-6A BR0011297A BR0011297A BR 0011297 A BR0011297 A BR 0011297A BR 0011297 A BR0011297 A BR 0011297A BR 0011297 A BR0011297 A BR 0011297A
Authority
BR
Brazil
Prior art keywords
identification
removal
nucleic acids
present
library
Prior art date
Application number
BR0011297-6A
Other languages
English (en)
Inventor
Steven Perrin
Katherine Call
Timothy Connolly
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of BR0011297A publication Critical patent/BR0011297A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Ceramic Products (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Patente de Invenção: "HIBRIDAçãO SUBTRATIVA à BASE DE MICRO-SISTEMA". A invenção se refere a um método altamente eficiente, de alto rendimento para a identificação e eliminação de redundância em uma população de moléculas de ácidos nucleicos. Este método envolve um protocolo de subtração reiterativa usando uma biblioteca que se torna mais propensa para genes desconhecidos com cada rodada sucessiva. A remoção de ácidos nucleicos repetitivos e caracterizados previamente da biblioteca permite a identificação de RNAm de baixa abundância a partir de fontes de interesse e aumenta o índice de descoberta de novos genes. A presente invenção também é útil para a remoção de ácidos nucleicos contaminantes das bibliotecas de clonagem.
BR0011297-6A 1999-05-19 2000-05-19 Hibridação subtrativa à base de micro-sistema BR0011297A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/314,698 US6638717B2 (en) 1999-05-19 1999-05-19 Microarray-based subtractive hybridzation
PCT/US2000/013789 WO2000070098A1 (en) 1999-05-19 2000-05-19 Microarray-based subtractive hybridization

Publications (1)

Publication Number Publication Date
BR0011297A true BR0011297A (pt) 2002-02-26

Family

ID=23221053

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0011297-6A BR0011297A (pt) 1999-05-19 2000-05-19 Hibridação subtrativa à base de micro-sistema

Country Status (18)

Country Link
US (1) US6638717B2 (pt)
EP (1) EP1185699B1 (pt)
JP (1) JP4714883B2 (pt)
KR (1) KR100733930B1 (pt)
AT (1) ATE382097T1 (pt)
AU (1) AU779901B2 (pt)
BR (1) BR0011297A (pt)
CA (1) CA2372698C (pt)
CY (1) CY1107428T1 (pt)
DE (1) DE60037584T2 (pt)
DK (1) DK1185699T3 (pt)
ES (1) ES2296623T3 (pt)
IL (2) IL146547A0 (pt)
MX (1) MXPA01011730A (pt)
NO (1) NO330813B1 (pt)
PT (1) PT1185699E (pt)
WO (1) WO2000070098A1 (pt)
ZA (1) ZA200109609B (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050272056A1 (en) * 1996-11-13 2005-12-08 Deiss Louis P Gene identification method
US20020142341A1 (en) * 2001-03-28 2002-10-03 Makoto Kameyama Method and apparatus for producing probe carrier
US20040110153A1 (en) * 2002-12-10 2004-06-10 Affymetrix, Inc. Compleixity management of genomic DNA by semi-specific amplification
JP4182338B2 (ja) * 2003-03-06 2008-11-19 信越化学工業株式会社 熱硬化性パーフルオロポリエーテル系ゴム組成物及びゴム製品
US7300755B1 (en) * 2003-05-12 2007-11-27 Fred Hutchinson Cancer Research Center Methods for haplotyping genomic DNA
US7044966B2 (en) 2003-10-06 2006-05-16 3F Therapeutics, Inc. Minimally invasive valve replacement system
EP1771563A2 (en) 2004-05-28 2007-04-11 Ambion, Inc. METHODS AND COMPOSITIONS INVOLVING MicroRNA
ES2534304T3 (es) 2004-11-12 2015-04-21 Asuragen, Inc. Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
CA2663962A1 (en) 2006-09-19 2008-03-27 Asuragen, Inc. Mir-15, mir-26, mir-31,mir-145, mir-147, mir-188, mir-215, mir-216, mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention
EP2487240B1 (en) 2006-09-19 2016-11-16 Interpace Diagnostics, LLC Micrornas differentially expressed in pancreatic diseases and uses thereof
GB0618514D0 (en) * 2006-09-20 2006-11-01 Univ Nottingham Trent Method of detecting interactions on a microarray using nuclear magnetic resonance
US8716190B2 (en) 2007-09-14 2014-05-06 Affymetrix, Inc. Amplification and analysis of selected targets on solid supports
US9388457B2 (en) 2007-09-14 2016-07-12 Affymetrix, Inc. Locus specific amplification using array probes
EP2990487A1 (en) 2008-05-08 2016-03-02 Asuragen, INC. Compositions and methods related to mirna modulation of neovascularization or angiogenesis
JP5221248B2 (ja) * 2008-08-26 2013-06-26 株式会社日立ハイテクノロジーズ 高発現遺伝子由来のｃＤＮＡクローンの含有率を低減させたｃＤＮＡライブラリーの作製方法
US20100331204A1 (en) * 2009-02-13 2010-12-30 Jeff Jeddeloh Methods and systems for enrichment of target genomic sequences
US20110059453A1 (en) * 2009-08-23 2011-03-10 Affymetrix, Inc. Poly(A) Tail Length Measurement by PCR
EP2542678B1 (en) 2010-03-04 2017-04-12 InteRNA Technologies B.V. A MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS THERAPEUTIC USES IN CANCER ASSOCIATED WITH EMT
CA2804599C (en) 2010-07-06 2023-01-31 Interna Technologies Bv Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
EP2640851A2 (en) 2010-11-17 2013-09-25 Asuragen, Inc. Mirnas as biomarkers for distinguishing benign from malignant thyroid neoplasms
EP2474617A1 (en) 2011-01-11 2012-07-11 InteRNA Technologies BV Mir for treating neo-angiogenesis
EP2681566A2 (en) 2011-02-28 2014-01-08 University of Iowa Research Foundation Anti-müllerian hormone changes in pregnancy and prediction ofadverse pregnancy outcomes and gender
MX2013012709A (es) 2011-05-02 2013-12-06 Pioneer Hi Bred Int Estrategia de analisis de arnm bacteriano para descubrir nuevas moleculas de acido nucleico codificante de pesticidas.
WO2013040251A2 (en) 2011-09-13 2013-03-21 Asurgen, Inc. Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease
US20130157884A1 (en) 2011-10-26 2013-06-20 Asuragen, Inc. Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts
EP2771487A1 (en) 2011-10-27 2014-09-03 Asuragen, INC. Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors
US20150152499A1 (en) 2012-07-03 2015-06-04 Interna Technologies B.V. Diagnostic portfolio and its uses
US20140100124A1 (en) 2012-10-04 2014-04-10 Asuragen, Inc. Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions
EP2971132B1 (en) 2013-03-15 2020-05-06 Baylor Research Institute Tissue and blood-based mirna biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer
EP2971149B1 (en) 2013-03-15 2018-05-09 Baylor Research Institute Ulcerative colitis (uc)-associated colorectal neoplasia markers
EP3404116B1 (en) 2013-03-15 2022-10-19 The University of Chicago Methods and compositions related to t-cell activity
KR101516976B1 (ko) * 2013-10-30 2015-05-04 에스케이텔레콤 주식회사 표적 염기 서열 해독에서의 바이어스 제거 방법
AU2018358016A1 (en) 2017-11-03 2020-05-07 Interna Technologies B.V. MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
JP7566775B2 (ja) 2019-04-12 2024-10-15 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 筋肉量及び酸化的代謝を増加させるための組成物及び方法
WO2024028794A1 (en) 2022-08-02 2024-02-08 Temple Therapeutics BV Methods for treating endometrial and ovarian hyperproliferative disorders

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821058A (en) 1984-01-16 1998-10-13 California Institute Of Technology Automated DNA sequencing technique
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5591575A (en) 1993-04-07 1997-01-07 Amersham International Plc Subtraction hybridization employing aziridinylbenoquinone cross-linking agents
US5482845A (en) 1993-09-24 1996-01-09 The Trustees Of Columbia University In The City Of New York Method for construction of normalized cDNA libraries
US5690894A (en) * 1995-05-23 1997-11-25 The Regents Of The University Of California High density array fabrication and readout method for a fiber optic biosensor
US5728529A (en) 1995-06-23 1998-03-17 Baylor College Of Medicine Alternative dye-labeled ribonucleotides, deoxyribonucleotides, and dideoxyribonucleotides for automated DNA analysis
US5851772A (en) 1996-01-29 1998-12-22 University Of Chicago Microchip method for the enrichment of specific DNA sequences
US5712127A (en) 1996-04-29 1998-01-27 Genescape Inc. Subtractive amplification
US5827658A (en) 1996-08-09 1998-10-27 The United States Of America As Reprsented By The Department Of Health And Human Services Isolation of amplified genes via cDNA subtractive hybridization
GB9618050D0 (en) 1996-08-29 1996-10-09 Cancer Res Campaign Tech Global amplification of nucleic acids
US5846721A (en) 1996-09-19 1998-12-08 The Trustees Of Columbia University In The City Of New York Efficient and simpler method to construct normalized cDNA libraries with improved representations of full-length cDNAs
US5953727A (en) * 1996-10-10 1999-09-14 Incyte Pharmaceuticals, Inc. Project-based full-length biomolecular sequence database
JP2002507275A (ja) 1997-03-24 2002-03-05 スミスクライン・ビーチャム・コーポレイション 引き算ライブラリーの製造方法
US6399334B1 (en) 1997-09-24 2002-06-04 Invitrogen Corporation Normalized nucleic acid libraries and methods of production thereof
AU753505B2 (en) 1997-10-30 2002-10-17 Cold Spring Harbor Laboratory Probe arrays and methods of using probe arrays for distinguishing DNA
US5882874A (en) 1998-02-27 1999-03-16 The Trustees Of Columbia University In The City Of New York Reciprocal subtraction differential display

Also Published As

Publication number Publication date
ZA200109609B (en) 2003-04-30
KR100733930B1 (ko) 2007-07-03
CA2372698A1 (en) 2000-11-23
EP1185699B1 (en) 2007-12-26
DE60037584D1 (de) 2008-02-07
US20020051970A1 (en) 2002-05-02
WO2000070098A1 (en) 2000-11-23
PT1185699E (pt) 2008-02-26
EP1185699A1 (en) 2002-03-13
MXPA01011730A (es) 2002-04-24
DE60037584T2 (de) 2009-01-08
US6638717B2 (en) 2003-10-28
NO330813B1 (no) 2011-07-25
CY1107428T1 (el) 2012-12-19
CA2372698C (en) 2010-04-27
AU5145500A (en) 2000-12-05
JP4714883B2 (ja) 2011-06-29
IL146547A0 (en) 2002-07-25
ATE382097T1 (de) 2008-01-15
IL146547A (en) 2008-04-13
NO20015635D0 (no) 2001-11-19
JP2002543856A (ja) 2002-12-24
AU779901B2 (en) 2005-02-17
ES2296623T3 (es) 2008-05-01
NO20015635L (no) 2002-01-15
KR20020008190A (ko) 2002-01-29
DK1185699T3 (da) 2008-04-28

Similar Documents

Publication Publication Date Title
BR0011297A (pt) Hibridação subtrativa à base de micro-sistema
US5780231A (en) DNA extension and analysis with rolling primers
US5763175A (en) Simultaneous sequencing of tagged polynucleotides
Li et al. RASL‐seq for massively parallel and quantitative analysis of gene expression
ATE343586T1 (de) Verfahren zur verwendung einer universellen bibliothek von peptid-nukleinsäuren zur optimierung der dns-hybridisierung
Myllykangas et al. Overview of sequencing technology platforms
Oberley et al. High-throughput screening of chromatin immunoprecipitates using CpG-island microarrays
US5962228A (en) DNA extension and analysis with rolling primers
Hirst et al. Next generation sequencing based approaches to epigenomics
Raine et al. SPlinted Ligation Adapter Tagging (SPLAT), a novel library preparation method for whole genome bisulphite sequencing
WO2000040755A3 (en) Method for accelerating identification of single nucleotide polymorphisms and alignment of clones in genomic sequencing
Bai et al. Design and synthesis of a photocleavable biotinylated nucleotide for DNA analysis by mass spectrometry
DK1159453T3 (da) Fremgangsmåde til direkte nukleinsyresekventering
KR20080005196A (ko) 분석용 폴리뉴클레오티드의 제조방법
DE69913509D1 (de) Bibliotheken von unterschiedlich markierten oligomeren
WO2003052099A3 (en) Methods of parallel gene cloning and analysis
CN110964794A (zh) 适用于dna编码化合物测序文库测序的引物
Akintunde et al. The evolution of next-generation sequencing technologies
JP2001521398A (ja) 性状検査用ｄｎａ
Peat et al. Low input whole-genome bisulfite sequencing using a post-bisulfite adapter tagging approach
US6670120B1 (en) Categorising nucleic acid
Mancia Genome-wide DNA Methylation protocol for epigenetics studies
EP4155416B1 (en) Method for obtaining spatial and sequencing information of m-rna from tissue
Ha et al. Library construction for high-throughput mobile element identification and genotyping
Reed et al. Single-cell whole genome amplification and sequencing to study neuronal mosaicism and diversity

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1927 DE 11/12/2007.